Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01956773 · ClinicalTrials.gov registry record · NA
Family Health History in Diverse Care Settings (FHH)
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 2,620
- Enrollment target
NCT01956773: Completed NA study, sponsored by Duke University.
NCT01956773 is a NA study that has completed, run by Duke University. The registered enrollment target is 2,620 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01956773, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,620 participants
- Enrollment target
Study Summary
The outcome of this research will be a demonstration that family health history (FHH) risk data can be used efficiently to deliver more effective healthcare in geographically and ethnically diverse clinical care environments. Although FHH is a standard component of the medical interview its widespread adoption is hindered by three major barriers: (1) a dearth of standard collection methods; (2) the absence of health care provider access to complete FHH information; and (3) the need for clinical guidance for the interpretation and use of FHH. In addition, the time constraints of the busy provider and poor integration of FHH with paper medical records or electronic medical records (EMR) impede its widespread use. The investigators hypothesize that patient-driven and electronic collection of FHH for risk stratification will promote more informed decision-making by patients and providers, and improves adherence to risk-stratified preventive care guidelines. The study team will use an implementation sciences approach to integrate an innovative FHH system that collects FHH from patients. Intermountain Healthcare will provide the information technology expertise with EMR design to develop an innovative solution to a storage model standard for FHH data as well as a centralized standards-compliant open clinical decision support (OpenCDS) rule development architecture to analyze FHH and to generate evidence-based, individualized, disease risk, preventive care recommendations for both patients and providers.
Primary Outcome
How many patients identified as meeting criteria for genetic counseling, how many providers ordered genetic counseling, and how many patients adhere to the provider recommendation at 1 year.
Interventions
- OTHER MeTree
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,620 participants |
| Start Date | 2014-04-11 |
| Est. Completion | 2017-10-31 |
| Phase | NA |
What the finished NCT01956773 record still lists
NCT01956773 is an interventional study that assigns participants to a tested intervention. Its 2,620 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% higher).
The record links to 0 conditions, and to 1 intervention - of which MeTree is the first listed.
NCT01956773 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01956773 about?
NCT01956773 is a clinical study titled "Family Health History in Diverse Care Settings (FHH)". The outcome of this research will be a demonstration that family health history (FHH) risk data can be used efficiently to deliver more effective healthcare in geographically and ethnically diverse clinical care environments. Although FHH is a standard component of the medical interview its widespre...
What is the current status of trial NCT01956773?
This trial is currently completed. It is a NA study. The enrollment target is 2,620 participants. The study started on 2014-04-11. Estimated completion is 2017-10-31.
What interventions are being tested in trial NCT01956773?
The interventions under investigation include: MeTree (OTHER).
Who is sponsoring clinical trial NCT01956773?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01956773's enrollment target sits among peer trials
2,620 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06455085 · 2,634 participants · NA
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
- NCT06033950 · 2,600 participants · Phase 3
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
- NCT06574672 · 2,600 participants · NA
Embedded Palliative Care in the MICU
- NCT06370520 · 2,592 participants
Screening Emotions in Adolescents at the Hospital for mTBI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI